Core binding factor beta (CBFB) haploinsufficiency due to an interstitial deletion at 16q21q22 resulting in delayed cranial ossification, cleft palate, congenital heart anomalies, and feeding difficulties but favorable outcome

Aneal Khan, R. Katherine Hyde, Amalia Dutra, Patrick Mohide, Paul Liu

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The core binding factor beta gene (CBFB), essential to bone morphogenesis, is located at 16q22.1. Homozygous deficiency of CBFB leads to ossification defects in mice. CBFB forms a heterodimer with RUNX2 (CBFA1) during embryonic bone development. RUNX2 mutations lead to cleidocranial dysplasia in humans. We describe an infant boy with an interstitial deletion of 16q21q22, delayed skull ossification, cleft palate, and heart anomalies who had a difficult course in infancy but eventually improved and is healthy. He was found to have CBFB haploinsufficiency, but did not have mutations in RUNX2. We suggest that 16q21q22 deletion be considered when there are antenatal or postnatal findings of enlarged cranial sutures with or without cleft palate. The finding of CBFB haploinsufficiency in our case and the similarity of cranial ossification defects with a mouse model of CBFB deletion suggest a role for CBFB in cranial bone development in humans.

Original languageEnglish (US)
Pages (from-to)2349-2354
Number of pages6
JournalAmerican Journal of Medical Genetics, Part A
Volume140
Issue number21
DOIs
StatePublished - Nov 1 2006

Fingerprint

Core Binding Factor beta Subunit
Haploinsufficiency
Cleft Palate
Osteogenesis
Bone Development
Cleidocranial Dysplasia
Cranial Sutures
Mutation
Essential Genes
Morphogenesis
Skull
Embryonic Development
Bone and Bones

Keywords

  • 16q21
  • CBFB
  • Core binding factor
  • Cranial suture diastasis
  • Deletion

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

@article{a31fbc3f5c684efcb5164c30319cf64c,
title = "Core binding factor beta (CBFB) haploinsufficiency due to an interstitial deletion at 16q21q22 resulting in delayed cranial ossification, cleft palate, congenital heart anomalies, and feeding difficulties but favorable outcome",
abstract = "The core binding factor beta gene (CBFB), essential to bone morphogenesis, is located at 16q22.1. Homozygous deficiency of CBFB leads to ossification defects in mice. CBFB forms a heterodimer with RUNX2 (CBFA1) during embryonic bone development. RUNX2 mutations lead to cleidocranial dysplasia in humans. We describe an infant boy with an interstitial deletion of 16q21q22, delayed skull ossification, cleft palate, and heart anomalies who had a difficult course in infancy but eventually improved and is healthy. He was found to have CBFB haploinsufficiency, but did not have mutations in RUNX2. We suggest that 16q21q22 deletion be considered when there are antenatal or postnatal findings of enlarged cranial sutures with or without cleft palate. The finding of CBFB haploinsufficiency in our case and the similarity of cranial ossification defects with a mouse model of CBFB deletion suggest a role for CBFB in cranial bone development in humans.",
keywords = "16q21, CBFB, Core binding factor, Cranial suture diastasis, Deletion",
author = "Aneal Khan and Hyde, {R. Katherine} and Amalia Dutra and Patrick Mohide and Paul Liu",
year = "2006",
month = "11",
day = "1",
doi = "10.1002/ajmg.a.31479",
language = "English (US)",
volume = "140",
pages = "2349--2354",
journal = "American Journal of Medical Genetics, Part A",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "21",

}

TY - JOUR

T1 - Core binding factor beta (CBFB) haploinsufficiency due to an interstitial deletion at 16q21q22 resulting in delayed cranial ossification, cleft palate, congenital heart anomalies, and feeding difficulties but favorable outcome

AU - Khan, Aneal

AU - Hyde, R. Katherine

AU - Dutra, Amalia

AU - Mohide, Patrick

AU - Liu, Paul

PY - 2006/11/1

Y1 - 2006/11/1

N2 - The core binding factor beta gene (CBFB), essential to bone morphogenesis, is located at 16q22.1. Homozygous deficiency of CBFB leads to ossification defects in mice. CBFB forms a heterodimer with RUNX2 (CBFA1) during embryonic bone development. RUNX2 mutations lead to cleidocranial dysplasia in humans. We describe an infant boy with an interstitial deletion of 16q21q22, delayed skull ossification, cleft palate, and heart anomalies who had a difficult course in infancy but eventually improved and is healthy. He was found to have CBFB haploinsufficiency, but did not have mutations in RUNX2. We suggest that 16q21q22 deletion be considered when there are antenatal or postnatal findings of enlarged cranial sutures with or without cleft palate. The finding of CBFB haploinsufficiency in our case and the similarity of cranial ossification defects with a mouse model of CBFB deletion suggest a role for CBFB in cranial bone development in humans.

AB - The core binding factor beta gene (CBFB), essential to bone morphogenesis, is located at 16q22.1. Homozygous deficiency of CBFB leads to ossification defects in mice. CBFB forms a heterodimer with RUNX2 (CBFA1) during embryonic bone development. RUNX2 mutations lead to cleidocranial dysplasia in humans. We describe an infant boy with an interstitial deletion of 16q21q22, delayed skull ossification, cleft palate, and heart anomalies who had a difficult course in infancy but eventually improved and is healthy. He was found to have CBFB haploinsufficiency, but did not have mutations in RUNX2. We suggest that 16q21q22 deletion be considered when there are antenatal or postnatal findings of enlarged cranial sutures with or without cleft palate. The finding of CBFB haploinsufficiency in our case and the similarity of cranial ossification defects with a mouse model of CBFB deletion suggest a role for CBFB in cranial bone development in humans.

KW - 16q21

KW - CBFB

KW - Core binding factor

KW - Cranial suture diastasis

KW - Deletion

UR - http://www.scopus.com/inward/record.url?scp=33750575433&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750575433&partnerID=8YFLogxK

U2 - 10.1002/ajmg.a.31479

DO - 10.1002/ajmg.a.31479

M3 - Article

C2 - 17022082

AN - SCOPUS:33750575433

VL - 140

SP - 2349

EP - 2354

JO - American Journal of Medical Genetics, Part A

JF - American Journal of Medical Genetics, Part A

SN - 1552-4825

IS - 21

ER -